Furthermore, CAR T-cells directed against the alpha-folate receptor overexpressed on ovarian cancer cells showed limited in vivo persistence and did not lead to any meaningful antitumor responses in patients with relapsed ovarian cancer despite encouraging preclinical results (Kershaw et al., 2006). The gene discussed is FOLR1; the disease is ovarian cancer.